CN | EN

Countdown to 2018 CBIIC:

ZHANG Dan

Secretary-general of the Association of “Thousand Talent” Expert

Executive Chairman of Fountain Medical Development Ltd


Dr. ZHANG Dan is the Executive Chairman of Fountain Medical Development Ltd, a clinical CRO with 1400 employees operating in China, Hong Kong, Taiwan, South Korea, Japan, UK, India, Philippines, Armenia & USA. Dr. Zhang was the Head of Clinical Development at Sigma-Tau Research Inc, vice president at the Quintiles Transnational Corp and Chairman of Quintiles Medical Development (Shanghai) Company Ltd. Dr. Zhang is a member of grant review committee for National Drug Development Fund of China, and is also a consultant for the China Food and Drug Administration (CFDA). He chairs the ICH E19 working group. He is also chairing the committee of Pharmaceutical R&D, China Pharmaceutical Industry Research and Development Association. Dr. Zhang is also a senior consultant for the Chinese Academy of Medical Sciences and Peking Union Medical College. He was a member of the Overseas Expert Committee on New Drug R&D for the Ministry of Science and Technology of China, and was the secretary-general of the Association of “Thousand Talent” Expert from 2011-2017. Dr. Zhang received his pre-med training from Peking University and received M.D. from Peking Union Medical College. He then went to the Harvard School of Public Health and received MPH in health policy and management. Then he went to the Wharton Business School of the University of Pennsylvania, where he obtained his master’s degree in healthcare management in 1998.